Speaking to MNT , Manish Mittal, MD, hair transplant surgeon at Mittal Hair Clinic, who was not involved in this study, explained that the vast majority of patients will never experience clinically significant hair loss, but the study reinforces that shedding can occur in a small proportion of people and is something clinicians should discuss before treatment. Thus, individuals taking GLP-1 medications for type 2 diabetes should be aware of all options available to them, which could include SGLT-2 inhibitors and DPP-4 inhibitors, depending on individual circumstances
Like GLP-1, glucagon acts centrally and peripherally to regulate energy and glucose homeostasis
Polymorphisms in TNFAIP3 and elevated levels of circulating proteasomes are also associated with RA, further implicating the UPS in disease pathogenesis
Until fully implemented in 2027, CMS set up the Bridge to provide GLP-1 drugs for qualified individuals until the BALANCE Model was up and running